Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Nice gains

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Jan 05, 2021 10:24am

207 Views

Post# 32223182

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nice gains

It will take some time and won't go up in a straight line but a 90% discount to peers is way too high even for tsx vs nasdaq. It should be a 33%-50% discount, or less if Sernova can secure a world-class strategic partner. Not to mention the fact that the peers we compare Sernova to are preclinical and treating diseases with much smaller markets.

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit